| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/19/2003 | EP1284423A2 Adrenic acid (delta 7,10,13,16 docosatetraenoic acid ) receptor and uses thereof |
| 02/19/2003 | EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 02/19/2003 | EP1284272A1 Estra-1,3,5(10)-triene derivatives |
| 02/19/2003 | EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1284260A1 Tyrosine phosphatase inhibitors |
| 02/19/2003 | EP1284257A2 Difluoromethylene aromatic ethers and their use as inhibitors of the glycine type-1 transporter |
| 02/19/2003 | EP1284141A2 Pharmaceutical combinations comprising neuronal nitric oxide synthase inhibitors for the treatment of neurodegenerative diseases |
| 02/19/2003 | EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver |
| 02/19/2003 | EP1283903A1 Drug screening systems and assays |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283839A1 Adenosine a2a receptor antagonists |
| 02/19/2003 | EP1283838A1 Piperazine and piperidine compounds |
| 02/19/2003 | EP1283837A1 New thiochromane derivatives and their use as thrombin inhibitors |
| 02/19/2003 | EP1283836A2 Neuroprotective and anti-proliferative compounds |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283830A1 Para-amine substituted phenylamide glucokinase activators |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283729A2 Tc and re carbonyl complexes for pertechnetate and perrhenate |
| 02/19/2003 | EP1283726A2 Dendritic cells loaded with toxic substances |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283710A1 Use of a celecoxib composition for fast pain relief |
| 02/19/2003 | EP1283682A2 Tryptophan source from plants and uses therefor |
| 02/19/2003 | EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists |
| 02/19/2003 | EP1115729B1 Phosphonic acid derivatives as inhibitors of ptp-1b |
| 02/19/2003 | EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398258A 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1398185A Method to potentiate therapueutic efficiency of taxane and derivatives thereof |
| 02/19/2003 | CN1398182A Dual inhibitors of cholestery lester and wax ester synthesis for sebaceous gland disorders |
| 02/19/2003 | CN1398181A Method and compsns. for treating inflammatory disease |
| 02/19/2003 | CN1398179A Cosmetic prepns. contg. waltheria indica extracts |
| 02/19/2003 | CN1397557A NOvel octahydro-2H-pyridino-[1,2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 02/19/2003 | CN1397332A Medicine for treating acute or chronic infantile convulsion |
| 02/19/2003 | CN1397326A Chinese-medicinal injection for treating growth of pig and its preparing process |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/19/2003 | CN1101813C 3-pyrazolecarboxamide derivs, having cannabinoid receptor affinity |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/19/2003 | CN1101683C Process to obtain oestrogens from mare's urine |
| 02/19/2003 | CN1101682C Method to obtain oestrogens from mare's urine |
| 02/18/2003 | WO2002018356A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521757 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 02/18/2003 | US6521755 Process for preparing 10,11-methanobenzosuberane derivatives |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521741 Catalytic antibodies and a method of producing same |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/18/2003 | US6521658 Cell proliferation inhibitors |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 02/18/2003 | US6521655 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521650 Amines as pharmaceutical agents |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521644 Compositions for promoting growth |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | US6521642 Crystal form of etoricoxib, a selective cyclooxygenase-2 inhibitor, useful in treatment of inflammation, pain and fever |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521630 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
| 02/18/2003 | US6521626 Inhibiting binding of alpha 4 integrins to their ligands; prophylaxis and treatment of immune or inflammatory disorders |
| 02/18/2003 | US6521623 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/18/2003 | US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/18/2003 | US6521616 Administering taurolidine, taurultam, or a biologically active derivative; induces tumor cell death by apoptosis. |
| 02/18/2003 | US6521611 2-(azetidin-2-on-1-yl) acetic acid derivatives; treatment of obsessive-compulsive disorder |
| 02/18/2003 | US6521606 Matrix metalloproteinase inhibitors |
| 02/18/2003 | US6521604 Compounds containing boron for energy-filtering transmission electron microscopy and for boron neutron-capture therapy |
| 02/18/2003 | US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance |
| 02/18/2003 | US6521593 Using antagonists of integrins such as alpha v beta 3 and alpha v beta 5; inhibiting angiogenesis and vitronectin and tenascin mediated cell adhesion; inducing apoptosis |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| 02/18/2003 | US6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 |
| 02/18/2003 | US6521262 Solid instant-release forms of administration and process for producing the same |
| 02/18/2003 | US6521259 Controlled release material comprising polyanhydrides, copolymers of lactic acid and glycolic acid, polylactic acid, polyglycolic acid, polyesters, polyorthoesters, proteins, polysaccharides; ouabain, digoxin |
| 02/18/2003 | US6521253 Low molecular weight peptide thrombin inhibitor having pH dependent solubility and a combination of microcrystalline cellulose and sodium starch glycollate |
| 02/18/2003 | CA2419838A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/18/2003 | CA2085750C Osteoinductive pharmaceutical formulations |
| 02/18/2003 | CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/16/2003 | CA2397698A1 Difluoromethylene aromatic ethers as inhibitors of glycine transport |